1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 29 SEPTEMBER 2014

CNS Drug News 29 SEPTEMBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Companion Diagnostics Could See New Alzheimer's Drugs Succeed
Industry Brief - MedGenesis/Pfizer Enter Agreement For Potential PD Treatments
Industry Trend Analysis - AstraZeneca/Lilly Deal Shares Risk Over Potential Blockbuster Alzheimer's Drug
Industry Trend Analysis - Litigation Threatens Namenda Switch Plan
Industry Brief - TauRx Achieves Enrolment Target For Second Phase III Trial Of LMTX In AD
Industry Brief - Aricept Phase III Trial In Chinese Patients With Severe AD Meets Primary Endpoint
Industry Brief - Evotec And Partners Awarded Public Grants To Develop New MS Drug Candidates
Industry Trend Analysis - Eisai Extends Aricept's Lifecycle With Japanese Approval For DLB
Industry Trend Analysis - SDP Targets Growing Cell Therapy Market With SB623 Deal
Industry Brief - NovaDel Sells ZolpiMist NDA/Licence/Intellectual Property To Amherst
Industry Brief - Lundbeck Commences European Launch Of Brintellix In Denmark
Industry Trend Analysis - Abilify Successor On Course For FDA Approval In 2015
Industry Brief - Shire Reaches Final Agreement With US Government
Industry Brief - FDA Approves Abilify Maintena Dual-Chamber Syringe
Industry Brief - PAION Grants Licence To Yichang For M6G In China
Industry Brief - Galen To Sell Penthrox In UK/Ireland
Industry Brief - Actavis Confirms Generic Butrans Patent Challenge
Industry Brief - KemPharm Receives US Patent For Novel Prodrug Of Hydromorphone
Industry Brief - Trevena Granted Key US Composition Of Matter Patent For TRV130
Industry Brief - Lannett Launches Oxycodone Oral Solution In US
Industry Brief - Milestone Triggered As Selincro Enters Market In France
Industry Trend Analysis - Novo Nordisk To Invest In Obesity Research With New Unit
Industry Brief - Edison Announces EPI-743 Phase II Results In Rett Syndrome
Industry Brief - Acorda To Acquire Civitas Therapeutics
Industry Brief - SiteOne Completes Financing Round/Secures NIH Grant
Industry Brief - Avraham Raises Funds For Ongoing Ladostigil Phase IIb Trial

Table Of Contents

CNS Drug News 29 SEPTEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.